Henk Portengen
Henk Portengen publishes mostly in Oncology, Molecular Biology and Cancer Research, on topics such as Estrogen and related hormone effects, HER2/EGFR in Cancer Research and Breast Cancer Treatment Studies.
- World rank
- #340,305 of 7,710,434 ranked researchers
- Rank in Netherlands
- #8,601 of 107,149
- Works
- 50
- Citations
- 3.8k
- Citations per work
- 76.1
What does Henk Portengen research?
Henk Portengen's work is mostly in Biochemistry, Genetics and Molecular Biology (47%), Medicine (31%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2346.6%
- Health Sciences1530.8%
- Medicine1530.8%
- Everything else1122.6%
- 1Oncology20% of their works
- 2Molecular Biology18% of their works
- 3Cancer Research16% of their works
- 4Genetics13% of their works
- 5Endocrinology, Diabetes and Metabolism6% of their works
- 6Radiology, Nuclear Medicine and Imaging5% of their works
Research topics
Which keywords describe Henk Portengen's research?
The keywords of their largest research topics: Breast Cancer, Estrogen, Receptor, HER2, Survival Analysis, Trastuzumab, Breast Tumours and Gene Expression.
- p53
- Therapeutic Antibodies
- Neuroendocrine Tumors
- IGF-1
- Fc Receptors
- Gene Expression
- Trastuzumab
- HER2
- Estrogen
- Breast Cancer
- Receptor
- Survival Analysis
- Breast Tumours
- Cell Cycle
- HIF-1
- Insulin-like Growth Factors
- Pancreatic Neuroendocrine Tumors
- Warburg Effect
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Breast Cancer272 topics
- Estrogen141 topic
- Receptor141 topic
- HER2131 topic
- Survival Analysis132 topics
- Trastuzumab131 topic
- Breast Tumours81 topic
- Gene Expression81 topic
- Cell Cycle51 topic
- Fc Receptors51 topic
- HIF-151 topic
- IGF-151 topic
- Insulin-like Growth Factors51 topic
- Neuroendocrine Tumors51 topic
- Pancreatic Neuroendocrine Tumors51 topic
- Therapeutic Antibodies51 topic
- Warburg Effect51 topic
- p5351 topic
Where does Henk Portengen work?
Henk Portengen's main affiliation in the publication record is Rotterdam University of Applied Sciences, Netherlands.
How many publications and citations does Henk Portengen have?
OpenAlex counts 50 works and 3,804 citations for Henk Portengen, an h-index of 29, ranking #340,305 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Henk Portengen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.